JOURNAL HOME CME HOME THIS MONTH PAST ISSUES ETOC COLLECTIONS AUTHORS REVIEWERS EDITORIAL BOARD FEEDBACK RSS HELP
		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a colleague Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Bailey, P. L. Articles by Rozendaal, W. Search for Related Content PubMed PubMed Citation Articles by Bailey, P. L. Articles by Rozendaal, W.

Antagonism of Postoperative Opioid-Induced Respiratory Depression

Nalbuphine Versus Naloxone

Received from the Department of Anesthesiology, University of Utah Health Sciences Center, Salt Lake City, Utah.

Abstract

The authors compared naloxone and nalbuphine as antagonists of opioid-induced respiratory depression to determine the relative efficacies and safety of the two agents. In a double-blind, randomized fashion, 90 anesthetized patients received a mean dose of 25 µg/kg fentanyl during surgery. Inadequate spontaneous respirations at the end of anesthesia were treated with either naloxone 0.08 mg or nalbuphine 2.5 mg IV every 2 min while heart rate (HR), systolic and diastolic blood pressures (SBP, DBP), respiratory rate (RR), and tidal volume (TV) were measured at 2-min intervals. Arterial blood samples for analysis of Paco₂, Pao₂, and pH were drawn when spontaneous ventilation resumed, and 30 and 60 min later. Narcotic antagonism and respiration were deemed adequate when TV was 4 ml/kg and RR 8 breaths/min. Heart rate, SBP, DBP, TV and RR were recorded, as were the occurrence of renarcotization (RR < 8) and analgesic requirements every 5 min during the recovery room stay. Sixty of 90 patients required narcotic antagonism at the end of surgery. No patient required more than three doses (0.24 mg) of naloxone or four doses (10 mg) of nalbuphine. Both antagonists produced similar and moderate increases in SBP and HR while restoring adequate spontaneous ventilation. There were no significant differences in TV, RR, or arterial blood gases (ABGS) between the two groups after narcotic reversal. Five patients in whom respiratory depression was antagonized with naloxone and two receiving nalbuphine became renarcotized 30--90 min after entering the recovery room (not statistcally different), but patients given naloxone required analgesics for pain significantly more often than those reversed with nalbuphine (12 vs 5). With the exception of providing better immediate postoperative analgesia, small doses of nalbuphine and naloxone are equally effective and safe antagonists of opioid respiratory depression after operation.

Key Words: ANTAGONISTS—naloxone, nalbuphine • NARCOTICS—nalbuphine

This article has been cited by other articles:

				T. Mom, J.-E. Bazin, F. Commun, C. Dubray, A. Eschalier, C. Derbal, P. Avan, and L. Gilain Assessment of Postoperative Pain After Laryngeal Surgery for Cancer Arch Otolaryngol Head Neck Surg, July 1, 1998; 124(7): 794 - 798. [Abstract] [Full Text] [PDF]

Anesthesia & Analgesia® is published for the International Anesthesia Research Society® by Lippincott Williams & Wilkins with the assistance of Stanford University Libraries' HighWire Press®. Copyright 2006 by the International Anesthesia Research Society. Online ISSN: 1526-7598   Print ISSN: 0003-2999